D. Barrett

D. Monos, S. Grupp, T. Olson, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.

D. Teachey, D. Barrett, Yimei Li, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Partially CD3+-depleted unrelated and haploidentical donor PSCT has favorable GVHD and survival rates in pediatric hematologic malignancy.

D. Monos, D. Teachey, A. Seif, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.

V. Brown, G. Reid, A. Seif, 2009, Blood.

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T cell therapy.

S. Grupp, S. Hunger, C. Callahan, 2021, Blood.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Integrative bulk and single-cell profiling of pre-manufacture T-cell populations reveals factors mediating long-term persistence of CAR T-cell therapy.

Gregory M. Chen, Qin Zhu, Yasin Uzun, 2021, Cancer discovery.

A GATA Factor Mediates Cell Type-Restricted Induction of HLA-E Gene Transcription by Gamma Interferon

K. Gustafson, D. Barrett, Jing Wang, 2004, Molecular and Cellular Biology.

Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States

S. Grupp, U. Beier, D. Barrett, 2021, Frontiers in Immunology.

Cars in Leukemia: Relapse with Antigen-Negative Leukemia Originating from a Single B Cell Expressing the Leukemia-Targeting CAR

Tyler J. Reich, F. Bushman, S. Grupp, 2016 .

Neurotoxicity after CTL019 in a pediatric and young adult cohort

D. Teachey, S. Grupp, B. Banwell, 2018, Annals of neurology.

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.

D. Teachey, J. Fish, G. Reid, 2011, Blood.

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response

D. Weissman, S. Grupp, A. Resnick, 2019, Human gene therapy.

Donor-derived CD19 chimeric antigen receptor T cells

D. Barrett, Nathan Singh, 2015, Current opinion in hematology.

Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States

S. Grupp, U. Beier, D. Barrett, 2021, bioRxiv.

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Tyler J. Reich, F. Bushman, S. Grupp, 2018, Nature Medicine.

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

G. Wertheim, D. Teachey, S. Grupp, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release

Lucas H. Horan, S. Grupp, D. Barrett, 2018, Cell Discovery.

Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy.

S. Grupp, C. June, Xiaojun Liu, 2014, Cytotherapy.

CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum

S. Grupp, C. Hu, A. Bagashev, 2018, Molecular and Cellular Biology.

Efficacy of humanized CD19-targeted chimeric antigen receptor (CAR)-modified T cells in children with relapsed ALL.

D. Teachey, S. Grupp, D. Porter, 2016 .

Cellular therapy: Immune‐related complications

D. Teachey, D. Barrett, J. Oved, 2019, Immunological reviews.

Chimeric Antigen Receptor

S. Grupp, D. Barrett, 2015 .

Nanoscale, antigen encounter-dependent, IL-12 delivery by CAR T cells plus PD-L1 blockade for cancer treatment

Lei S. Qi, F. Marincola, Hana Choi, 2023, Journal of Translational Medicine.

Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children.

Jason W. Moore, D. Teachey, S. Grupp, 2020, Blood advances.

Pre-Clinical Development Of a Novel Chimerical Antigen Receptor Targeting High-Risk Pediatric ALL Over-Expressing Tslpr

S. Grupp, R. Orentas, T. Fry, 2013 .

Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

E. Puré, S. Albelda, E. Moon, 2015, Cancer Immunology Research.

Interleukin 6 Is Not Made By Chimeric Antigen Receptor T Cells and Does Not Impact Their Function

S. Grupp, T. Hofmann, D. Barrett, 2016 .

335 Analyses of severe immune-mediated toxicity in patients with advanced mCRPC treated with a PSMA-targeted armored CAR T-cells

C. June, A. Vultur, D. Barrett, 2022, Regular and Young Investigator Award Abstracts.

TmPSMA-02: A CD2 endodomain containing double armored PSMA CAR T with enhanced efficacy and lower immune toxicity.

D. Barrett, W. Gladney, Thomas J. Fountaine, 2022, Journal of Clinical Oncology.

Efficient Trafficking of Chimeric Antigen Receptor (CAR)-Modified T Cells to CSF and Induction of Durable CNS Remissions in Children with CNS/Combined Relapsed/Refractory ALL

Mark G. Duckworth, D. Teachey, S. Grupp, 2015 .

A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release

Lucas H. Horan, S. Grupp, D. Barrett, 2018, Cell Discovery.

Biomarkers Accurately Predict Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

D. Teachey, S. Grupp, D. Porter, 2015 .

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

S. Grupp, D. Porter, C. June, 2015 .

Effect of chimeric antigen receptor-modified T (CAR-T) cells on responses in children with non-CNS extramedullary relapse of CD19+ acute lymphoblastic leukemia (ALL).

D. Teachey, S. Grupp, B. Levine, 2017 .

Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia

G. Reid, A. Seif, S. Grupp, 2018, Leukemia.

Single Chain Variable Fragment Linker Length Regulates CAR Biology and T Cell Efficacy

Nathan H. Roy, S. Grupp, C. June, 2019, Blood.

Clinical Efficacy of Anti-CD22 Chimeric Antigen Receptor T Cells for B-Cell Acute Lymphoblastic Leukemia Is Correlated with the Length of the Scfv Linker and Can be Predicted Using Xenograft Models

S. Grupp, D. Porter, C. June, 2017 .

Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective

D. Monos, K. Sullivan, D. Teachey, 2021, Pediatric blood & cancer.

CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells

Yong Gu Lee, C. June, S. Schuster, 2020 .

CAR T Cells for Solid Tumors

D. Barrett, B. Moghimi, 2017, Current Stem Cell Reports.

Toxicity management for patients receiving novel T-cell engaging therapies

D. Teachey, S. Grupp, D. Barrett, 2014, Current opinion in pediatrics.

Ikaros Mediates Antigen Escape Following CD19 CAR T Cell Therapy in r/r B-ALL

K. Davis, Astraea Jager, S. Grupp, 2021, Blood.

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syndrome in B-Cell ALL Patients Receiving CART19.

D. Teachey, A. Seif, S. Grupp, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

The Pediatric Cell Atlas: Defining the Growth Phase of Human Development at Single-Cell Resolution.

Larry N. Singh, Timothy L. Tickle, Noor B. Dawany, 2019, Developmental cell.

Index of suspicion.

D. Barrett, C. Cho, J. Wenger, 2008, Pediatrics in review.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.

Nancy R. Zhang, Elizabeth H. Williams, Joshua F. McMichael, 2020, Cell.